Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Transfusion|May 1, 1985
Effects of hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysisR G Strauss, D C Stump, R A Henriksen, et al.
Laboratory Animal Science|August 1, 1988
Pancreatectomized swine as a model of diabetes mellitusK C Stump, M M Swindle, C D Saudek, et al.
Blood|April 1, 1988
Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activatorW H Dzik, C F Arkin, R L Jenkins, et al.
Thrombosis and Haemostasis|August 20, 1986
Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitroD Collen, F De Cock, E Demarsin, et al.
Thrombosis and Haemostasis|April 8, 1988
Monitoring of hemostasis parameters during coronary thrombolysis with recombinant tissue-type plasminogen activatorD C Stump, E J Topol, A B Chen, et al.
Transfusion|July 1, 1985
Effects of hydroxyethyl starch on blood coagulation, particularly factor VIIID C Stump, R G Strauss, R A Henriksen, et al.
The Journal of Biological Chemistry|November 25, 1990
Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cell cultureM A Shatos, J M Doherty, D C Stump, et al.
Circulation|October 1, 1990
Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysisP R Eisenberg, A S Jaffe, D C Stump, et al.
The Journal of Biological Chemistry|November 25, 1987
Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3M J Heeb, F España, M Geiger, et al.
ACS Applied Materials & Interfaces|July 31, 2019
New Functionality of Ionic Liquids as Lubricant Additives: Mitigating Rolling Contact FatigueBenjamin C Stump, Yan Zhou, Huimin Luo, et al.
Pageof 7